185 related articles for article (PubMed ID: 22449373)
1. Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation.
Park JW; Cho JW; Joo SY; Kim CS; Choi JS; Bae EH; Ma SK; Kim SH; Lee J; Kim SW
Eur J Pharmacol; 2012 May; 683(1-3):301-9. PubMed ID: 22449373
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats.
Park JW; Bae EH; Kim IJ; Ma SK; Choi C; Lee J; Kim SW
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F301-13. PubMed ID: 19940033
[TBL] [Abstract][Full Text] [Related]
3. Paricalcitol attenuates cyclosporine-induced kidney injury in rats.
Park JW; Bae EH; Kim IJ; Ma SK; Choi C; Lee J; Kim SW
Kidney Int; 2010 Jun; 77(12):1076-85. PubMed ID: 20237458
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of paricalcitol on cyclosporine-induced renal injury in rats.
Piao SG; Song JC; Lim SW; Chung BH; Choi BS; Yang CW
Transplant Proc; 2012 Apr; 44(3):642-5. PubMed ID: 22483459
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I increases p21 expression and attenuates cisplatin-induced acute renal injury in rats.
Yasuda H; Kato A; Miyaji T; Zhou H; Togawa A; Hishida A
Clin Exp Nephrol; 2004 Mar; 8(1):27-35. PubMed ID: 15067513
[TBL] [Abstract][Full Text] [Related]
6. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
[TBL] [Abstract][Full Text] [Related]
7. Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells.
Kim CS; Joo SY; Lee KE; Choi JS; Bae EH; Ma SK; Kim SH; Lee J; Kim SW
PLoS One; 2013; 8(5):e63186. PubMed ID: 23690997
[TBL] [Abstract][Full Text] [Related]
8. The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure.
Zhou H; Kato A; Yasuda H; Miyaji T; Fujigaki Y; Yamamoto T; Yonemura K; Hishida A
Toxicol Appl Pharmacol; 2004 Oct; 200(2):111-20. PubMed ID: 15476864
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines.
Chen CL; Chou KJ; Lee PT; Chen YS; Chang TY; Hsu CY; Huang WC; Chung HM; Fang HC
Exp Cell Res; 2010 Apr; 316(7):1109-18. PubMed ID: 20202468
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of oleuropein attenuates cisplatin-induced acute renal injury in mice through inhibition of ERK signaling.
Potočnjak I; Škoda M; Pernjak-Pugel E; Peršić MP; Domitrović R
Mol Nutr Food Res; 2016 Mar; 60(3):530-41. PubMed ID: 26603374
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-κB pathway in ischemia/reperfusion-induced acute kidney injury.
Lee JW; Kim SC; Ko YS; Lee HY; Cho E; Kim MG; Jo SK; Cho WY; Kim HK
Biochem Biophys Res Commun; 2014 Feb; 444(2):121-7. PubMed ID: 24434153
[TBL] [Abstract][Full Text] [Related]
13. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.
Tan X; Li Y; Liu Y
J Am Soc Nephrol; 2006 Dec; 17(12):3382-93. PubMed ID: 17082242
[TBL] [Abstract][Full Text] [Related]
14. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.
Jiang M; Wei Q; Wang J; Du Q; Yu J; Zhang L; Dong Z
Oncogene; 2006 Jul; 25(29):4056-66. PubMed ID: 16491117
[TBL] [Abstract][Full Text] [Related]
15. Paricalcitol attenuates indoxyl sulfate-induced apoptosis through the inhibition of MAPK, Akt, and NF-kB activation in HK-2 cells.
Park JS; Choi HI; Bae EH; Ma SK; Kim SW
Korean J Intern Med; 2019 Jan; 34(1):146-155. PubMed ID: 28992684
[TBL] [Abstract][Full Text] [Related]
16. Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice.
Wang YJ; Jeng JH; Chen RJ; Tseng H; Chen LC; Liang YC; Lin CH; Chen CH; Chu JS; Ho WL; Ho YS
Mol Carcinog; 2002 Aug; 34(4):199-210. PubMed ID: 12203371
[TBL] [Abstract][Full Text] [Related]
17. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.
Fan G; Ma X; Wong PY; Rodrigues CM; Steer CJ
Apoptosis; 2004 Mar; 9(2):211-21. PubMed ID: 15004518
[TBL] [Abstract][Full Text] [Related]
18. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
19. [Effects of bone morphogenic protein-7 on transdifferentiation and the expression of connective tissue growth factor of human renal tubular epithelial cells induced by transforming growth factor-beta1].
Xu YF; Wan JX; Jiang DW
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1639-44. PubMed ID: 19957515
[TBL] [Abstract][Full Text] [Related]
20. Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model.
Elsherbiny NM; Eladl MA; Al-Gayyar MM
Cytokine; 2016 Jan; 77():26-34. PubMed ID: 26517155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
